66 related articles for article (PubMed ID: 9329579)
1. Serum S-100 has prognostic significance in malignant melanoma.
Bonfrer JM; Korse CM; Israels SP
Anticancer Res; 1997; 17(4B):2975-7. PubMed ID: 9329579
[TBL] [Abstract][Full Text] [Related]
2. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
[TBL] [Abstract][Full Text] [Related]
3. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
Vos MJ; Postma TJ; Martens F; Uitdehaag BM; Blankenstein MA; Vandertop WP; Slotman BJ; Heimans JJ
Anticancer Res; 2004; 24(4):2511-4. PubMed ID: 15330206
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients.
Schmitz C; Brenner W; Henze E; Christophers E; Hauschild A
Anticancer Res; 2000; 20(6D):5059-63. PubMed ID: 11326668
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
7. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.
Abraha HD; Fuller LC; Du Vivier AW; Higgins EM; Sherwood RA
Br J Dermatol; 1997 Sep; 137(3):381-5. PubMed ID: 9349333
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum analyses of S-100 protein beta in malignant melanoma.
Hansson LO; von Schoultz E; Djureen E; Hansson J; Nilsson B; Ringborg U
Anticancer Res; 1997; 17(4B):3071-3. PubMed ID: 9329604
[TBL] [Abstract][Full Text] [Related]
10. S-100beta and MIA in advanced melanoma in relation to prognostic factors.
Auge JM; Molina R; Filella X; Bosch E; Gonzalez Cao M; Puig S; Malvehy J; Castel T; Ballesta AM
Anticancer Res; 2005; 25(3A):1779-82. PubMed ID: 16033099
[TBL] [Abstract][Full Text] [Related]
11. Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.
Smit LH; Nieweg OE; Mooi WJ; Bonfrer JM; Haanen JB; Kroon BB; De Gast GC
Anticancer Res; 2008; 28(4C):2297-302. PubMed ID: 18751409
[TBL] [Abstract][Full Text] [Related]
12. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
14. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
15. [Determination of serum S-100 protein and 5-S-cysteinyl-DOPA levels in melanoma patients].
Bánfalvi T; Bezzegh A; Edesné BM; Fejös Z; Liszkay G; Schumann B; Kremmer T; Ottó S; Gilde K
Orv Hetil; 1999 Mar; 140(11):599-602. PubMed ID: 10379169
[TBL] [Abstract][Full Text] [Related]
16. [Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].
Gu XH; Zhang G; Zhang XQ; Song Y; Wang T; Li SX
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):975-7. PubMed ID: 17650423
[TBL] [Abstract][Full Text] [Related]
17. Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients.
Pfeifer R; Ferrari M; Börner A; Deufel T; Figulla HR
Resuscitation; 2008 Oct; 79(1):46-53. PubMed ID: 18617311
[TBL] [Abstract][Full Text] [Related]
18. The value of serum S-100beta and interleukins as tumour markers in advanced melanoma.
Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E
Melanoma Res; 2000 Jun; 10(3):237-41. PubMed ID: 10890377
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
20. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]